These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 24437697)
1. High incidence of secondary hypertension in patients referred for renal denervation--the Copenhagen experience. Olsen LK; Kamper AL; Svendsen JH; Bang LE; Frimodt-Møller M; Kelbæk H; Sander M; Feldt-Rasmussen B Blood Press; 2014 Aug; 23(4):233-9. PubMed ID: 24437697 [TBL] [Abstract][Full Text] [Related]
2. Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension. Völz S; Andersson B; Manhem K; Haraldsson I; Rundqvist B Blood Press; 2014 Aug; 23(4):228-32. PubMed ID: 24432803 [TBL] [Abstract][Full Text] [Related]
3. [Renal denervation a treatment for resistant hypertension: a French experience]. Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC; Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients. Hayek SS; Abdou MH; Demoss BD; Legaspi JM; Veledar E; Deka A; Krishnan SK; Wilmot KA; Patel AD; Kumar VR; Devireddy CM Am J Hypertens; 2013 Dec; 26(12):1452-8. PubMed ID: 23934709 [TBL] [Abstract][Full Text] [Related]
5. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study. Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098 [TBL] [Abstract][Full Text] [Related]
6. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578 [TBL] [Abstract][Full Text] [Related]
7. Renal denervation: results of a single-center cohort study. Luetkens JA; Wilhelm K; Düsing R; Woitas RP; Thomas D; Hundt F; Doerner J; Schild HH; Nähle CP Rofo; 2015 Jan; 187(1):36-41. PubMed ID: 25188311 [TBL] [Abstract][Full Text] [Related]
8. Renal denervation in moderate treatment-resistant hypertension. Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901 [TBL] [Abstract][Full Text] [Related]
9. Eligibility for percutaneous renal denervation: the importance of a systematic screening. Verloop WL; Vink EE; Voskuil M; Vonken EJ; Rookmaaker MB; Bots ML; Doevendans PA; Blankestijn PJ; Spiering W J Hypertens; 2013 Aug; 31(8):1662-8. PubMed ID: 23743806 [TBL] [Abstract][Full Text] [Related]
10. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension. Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861 [TBL] [Abstract][Full Text] [Related]
11. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter. Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556 [TBL] [Abstract][Full Text] [Related]
12. [Frequency of hypertension resistant to treatment and indication for renal denervation]. Rosenbaum D; Villeneuve F; Gury C; Girerd X Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):229-33. PubMed ID: 22677181 [TBL] [Abstract][Full Text] [Related]
14. Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence. Persu A; Renkin J; Asayama K; O'Brien E; Staessen JA Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):739-49. PubMed ID: 23750683 [TBL] [Abstract][Full Text] [Related]
15. Eligibility for renal denervation: experience at 11 European expert centers. Persu A; Jin Y; Baelen M; Vink E; Verloop WL; Schmidt B; Blicher MK; Severino F; Wuerzner G; Taylor A; Pechère-Bertschi A; Jokhaji F; Fadl Elmula FE; Rosa J; Czarnecka D; Ehret G; Kahan T; Renkin J; Widimsky J; Jacobs L; Spiering W; Burnier M; Mark PB; Menne J; Olsen MH; Blankestijn PJ; Kjeldsen S; Bots ML; Staessen JA; Hypertension; 2014 Jun; 63(6):1319-25. PubMed ID: 24664290 [TBL] [Abstract][Full Text] [Related]
17. Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation. Patel P; Gupta PK; White CM; Stanley AG; Williams B; Tomaszewski M J Hum Hypertens; 2016 Jun; 30(6):368-73. PubMed ID: 26446393 [TBL] [Abstract][Full Text] [Related]
18. Effect of renal nerve denervation for resistant hypertension in Thai patients: a report of the first cases series in Thailand. Wongpraparut N; Tresukosol D; Roubsantisuk W; Buranakitjaroen P; Chotivoraniyakul C; Pongakasira R J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S155-61. PubMed ID: 24772593 [TBL] [Abstract][Full Text] [Related]
19. Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus. Wuerzner G; Muller O; Erne P; Cook S; Sudano I; Lüscher TF; Noll G; Kaufmann U; Rickli H; Waeber B; Kaiser C; Sticherling C; Pechère-Bertschi A; Baumgartner I; Jacob AL; Burnier M; Qanadli SD; ; ; ; Swiss Med Wkly; 2014 Mar; 144():w13913. PubMed ID: 24652665 [TBL] [Abstract][Full Text] [Related]